- Filed
- May 22, 2014 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2014 · May 20, 2014 | 31.39M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2014 | 31.39M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2014 | 31.39M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2013 | 31.39M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2013 | 31.39M sh |
| Operating Cash Flow | Q3 2014 · Mar 31, 2014 | −$42.97K |
| Long Term Debt | Q3 2014 · Mar 31, 2014 | $2.09M |
| Long Term Debt | Q3 2014 · Jun 30, 2013 | $1.95M |
| Cash And Equivalents | Q3 2014 · Mar 31, 2014 | $1.19K |
| Cash And Equivalents | Q3 2014 · Jun 30, 2013 | $50.16K |
| Cash And Equivalents restated | Q3 2014 · Mar 31, 2013 | −$6.57K |
| Cash And Equivalents | Q3 2014 · Dec 31, 2012 | $19.24K |
| Cash And Equivalents | Q3 2014 · Jun 30, 2012 | $5.51K |
| Stockholders Equity | Q3 2014 · Mar 31, 2014 | −$475.91K |
| Stockholders Equity | Q3 2014 · Jun 30, 2013 | −$330.73K |
| Current Liabilities | Q3 2014 · Mar 31, 2014 | $2.74M |
| Current Liabilities | Q3 2014 · Jun 30, 2013 | $2.47M |
| Total Liabilities | Q3 2014 · Mar 31, 2014 | $4.83M |
| Total Liabilities | Q3 2014 · Jun 30, 2013 | $4.42M |
| Current Assets | Q3 2014 · Mar 31, 2014 | $45.84K |
| Current Assets | Q3 2014 · Jun 30, 2013 | $72.68K |
| Total Assets | Q3 2014 · Mar 31, 2014 | $4.35M |
| Total Assets | Q3 2014 · Jun 30, 2013 | $4.09M |
| Sga Expense | Q3 2014 · Mar 31, 2014 | $36.63K |
| Sga Expense | Q3 2014 · Mar 31, 2014 | $138.93K |
| Sga Expense | Q3 2014 · Mar 31, 2013 | $36.25K |
| Sga Expense | Q3 2014 · Mar 31, 2013 | $105.76K |
| Net Income | Q3 2014 · Mar 31, 2014 | −$60.82K |
| Net Income | Q3 2014 · Mar 31, 2014 | −$204.86K |
| Net Income | Q3 2014 · Mar 31, 2013 | −$81.56K |
| Net Income | Q3 2014 · Mar 31, 2013 | −$236.91K |
| Operating Income | Q3 2014 · Mar 31, 2014 | $2.74K |
| Operating Income | Q3 2014 · Mar 31, 2014 | −$19.33K |
| Operating Income | Q3 2014 · Mar 31, 2013 | −$22.08K |
| Operating Income | Q3 2014 · Mar 31, 2013 | −$51.94K |
| Gross Profit | Q3 2014 · Mar 31, 2014 | $39.37K |
| Gross Profit | Q3 2014 · Mar 31, 2014 | $119.6K |
| Gross Profit | Q3 2014 · Mar 31, 2013 | $14.17K |
| Gross Profit | Q3 2014 · Mar 31, 2013 | $53.82K |
| Cost Of Revenue | Q3 2014 · Mar 31, 2014 | $39.42K |
| Cost Of Revenue | Q3 2014 · Mar 31, 2014 | $114.28K |
| Cost Of Revenue | Q3 2014 · Mar 31, 2013 | $35.7K |
| Cost Of Revenue | Q3 2014 · Mar 31, 2013 | $114.64K |
| Capex | Q3 2014 · Mar 31, 2013 | $677 |
| Eps Diluted | Q3 2014 · Mar 31, 2013 | −$0.01 |
| Eps Basic | Q3 2014 · Mar 31, 2013 | −$0.01 |